Brief: Nrx Pharmaceuticals Files Counterclaim Against Its Former Collaboration Partner, Relief Therapeutics

MindMaze Therapeutics Holding SA

12/01/2022 22:52

Jan 12 (Reuters) - NRX Pharmaceuticals Inc  NRXP.O :
    * NRX PHARMACEUTICALS FILES COUNTERCLAIM AGAINST ITS FORMER
COLLABORATION PARTNER, RELIEF THERAPEUTICS
    * NRX PHARMACEUTICALS INC - NRX SEEKS $185 MILLION IN
RELIANCE
DAMAGES AS WELL FURTHER PUNITIVE DAMAGES
    * NRX PHARMACEUTICALS INC - NRX ADVISED RELIEF TODAY THAT
THE
COLLABORATION AGREEMENT IS NO LONGER IN EFFECT
    * NRX PHARMACEUTICALS INC - LOOK FORWARD TO RESTARTING
ENROLLMENT
NEXT MONTH FOR OUR BREAKTHROUGH DRUG, NRX-101

Source text for Eikon:  ID:nPn3y1szZa 
Further company coverage:  NRXP.O 

 ((Reuters.Briefs@thomsonreuters.com;))